1887

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) causes Kaposi's sarcoma, primary effusion lymphoma and multicentric Castleman's disease. KSHV infection of cells produces both latent and lytic cycles of infection. , the virus is found predominantly in the latent state. , a lytic infection can be induced in KSHV-infected cells by treating with phorbol ester (TPA). However, the exact signalling events that lead to the reactivation of KSHV lytic infection are still elusive. Here, a role is demonstrated for B-Raf/MEK/ERK signalling in TPA-induced reactivation of KSHV latent infection. Inhibiting MEK/ERK signalling by using MEK-specific inhibitors decreased expression of the TPA-induced KSHV lytic-cycle gene ORF8. Transfection of BCBL-1 cells with B-Raf small interfering RNA inhibited TPA-induced KSHV lytic infection significantly. Additionally, overexpression of MEK1 induced a lytic cycle of KSHV infection in BCBL-1 cells. The significance of these findings in understanding the biology of KSHV-associated pathogenesis is discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81628-0
2006-05-01
2020-01-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/5/1139.html?itemId=/content/journal/jgv/10.1099/vir.0.81628-0&mimeType=html&fmt=ahah

References

  1. Akula, S. M., Pramod, N. P., Wang, F.-Z. & Chandran, B. ( 2001; ). Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Virology 284, 235–249.[CrossRef]
    [Google Scholar]
  2. Akula, S. M., Pramod, N. P., Wang, F.-Z. & Chandran, B. ( 2002; ). Integrin α3β1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108, 407–419.[CrossRef]
    [Google Scholar]
  3. Akula, S. M., Ford, P. W., Whitman, A. G., Hamden, K. E., Shelton, J. G. & McCubrey, J. A. ( 2004; ). Raf promotes human herpesvirus-8 (HHV-8/KSHV) infection. Oncogene 23, 5227–5241.[CrossRef]
    [Google Scholar]
  4. Akula, S. M., Ford, P. W., Whitman, A. G., Hamden, K. E., Bryan, B. A., Cook, P. P. & McCubrey, J. A. ( 2005; ). B-Raf-dependent expression of vascular endothelial growth factor-A in Kaposi sarcoma-associated herpesvirus-infected human B cells. Blood 105, 4516–4522.[CrossRef]
    [Google Scholar]
  5. An, F.-Q., Compitello, N., Horwitz, E., Sramkoski, M., Knudsen, E. S. & Renne, R. ( 2005; ). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest. J Biol Chem 280, 3862–3874.[CrossRef]
    [Google Scholar]
  6. Bryan, B. A., Dyson, O. F. & Akula, S. M. ( 2006; ). Identifying cellular genes crucial for the reactivation of Kaposi's sarcoma-associated herpesvirus latency. J Gen Virol 87, 519–529.[CrossRef]
    [Google Scholar]
  7. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M. & Moore, P. S. ( 1994; ). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865–1869.[CrossRef]
    [Google Scholar]
  8. Cook, S. D., Paveloff, M. J., Doucet, J. J., Cottingham, A. J., Sedarati, F. & Hill, J. M. ( 1991; ). Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants. Invest Ophthalmol Vis Sci 32, 1558–1561.
    [Google Scholar]
  9. Deutsch, E., Cohen, A., Kazimirsky, G., Dovrat, S., Rubinfeld, H., Brodie, C. & Sarid, R. ( 2004; ). Role of protein kinase C δ in reactivation of Kaposi's sarcoma-associated herpesvirus. J Virol 78, 10187–10192.[CrossRef]
    [Google Scholar]
  10. Ensoli, B., Sgadari, C., Barillari, G., Sirianni, M. C., Stürzl, M. & Monini, P. ( 2001; ). Biology of Kaposi's sarcoma. Eur J Cancer 37, 1251–1269.[CrossRef]
    [Google Scholar]
  11. Faris, M., Ensoli, B., Kokot, N. & Nel, A. E. ( 1998; ). Inflammatory cytokines induce the expression of basic fibroblast growth factor (bFGF) isoforms required for the growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements in the bFGF promoter. AIDS 12, 19–27.[CrossRef]
    [Google Scholar]
  12. Fenton, M. & Sinclair, A. J. ( 1999; ). Divergent requirements for the MAPKERK signal transduction pathway during initial virus infection of quiescent primary B cells and disruption of Epstein-Barr virus latency by phorbol esters. J Virol 73, 8913–8916.
    [Google Scholar]
  13. Friborg, J., Jr, Kong, W.-P., Hottiger, M. O. & Nabel, G. J. ( 1999; ). p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889–894.
    [Google Scholar]
  14. Fujimuro, M., Liu, J., Zhu, J., Yokosawa, H. & Hayward, S. D. ( 2005; ). Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. J Virol 79, 10429–10441.[CrossRef]
    [Google Scholar]
  15. Gao, X., Ikuta, K., Tajima, M. & Sairenji, T. ( 2001; ). 12-O-Tetradecanoylphorbol-13-acetate induces Epstein–Barr virus reactivation via NF-κB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase. Virology 286, 91–99.[CrossRef]
    [Google Scholar]
  16. Giri, R. K., Selvaraj, S. K. & Kalra, V. K. ( 2003; ). Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA. J Immunol 170, 5281–5294.[CrossRef]
    [Google Scholar]
  17. Hamden, K. E., Ford, P. W., Whitman, A. G., Dyson, O. F., Cheng, S.-Y., McCubrey, J. A. & Akula, S. M. ( 2004; ). Raf-induced vascular endothelial growth factor augments Kaposi's sarcoma-associated herpesvirus infection. J Virol 78, 13381–13390.[CrossRef]
    [Google Scholar]
  18. Jang, B.-C., Jung, T.-Y., Paik, J.-H., Kwon, Y.-K., Shin, S.-W., Kim, S.-P., Ha, J.-S., Suh, M.-H. & Suh, S.-I. ( 2005; ). Tetradecanoyl phorbol acetate induces expression of Toll-like receptor 2 in U937 cells: involvement of PKC, ERK, and NF-κB. Biochem Biophys Res Commun 328, 70–77.[CrossRef]
    [Google Scholar]
  19. Jenner, R. G., Albà, M. M., Boshoff, C. & Kellam, P. ( 2001; ). Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 75, 891–902.[CrossRef]
    [Google Scholar]
  20. Jordan, M. C., Jordan, G. W., Stevens, J. G. & Miller, G. ( 1984; ). Latent herpesviruses of humans. Ann Intern Med 100, 866–880.[CrossRef]
    [Google Scholar]
  21. Karasarides, M., Chiloeches, A., Hayward, R. & 9 other authors ( 2004; ). B-RAF is a therapeutic target in melanoma. Oncogene 23, 6292–6298.[CrossRef]
    [Google Scholar]
  22. Lan, K., Kuppers, D. A., Verma, S. C. & Robertson, E. S. ( 2004; ). Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J Virol 78, 6585–6594.[CrossRef]
    [Google Scholar]
  23. Man, K., Ng, K. T., Lee, T. K., Lo, C. M., Sun, C. K., Li, X. L., Zhao, Y., Ho, J. W. & Fan, S. T. ( 2005; ). FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers. Am J Transplant 5, 40–49.[CrossRef]
    [Google Scholar]
  24. Marquardt, B., Frith, D. & Stabel, S. ( 1994; ). Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 9, 3213–3218.
    [Google Scholar]
  25. Matsubara, M., Tamura, T., Ohmori, K. & Hasegawa, K. ( 2005; ). Histamine H1 receptor antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf/MEK/ERK and IKK/IκB/NF-κB signal cascades. Biochem Pharmacol 69, 433–449.[CrossRef]
    [Google Scholar]
  26. Nakayama, K., Ota, Y., Okugawa, S., Ise, N., Kitazawa, T., Tsukada, K., Kawada, M., Yanagimoto, S. & Kimura, S. ( 2003; ). Raf1 plays a pivotal role in lipopolysaccharide-induced activation of dendritic cells. Biochem Biophys Res Commun 308, 353–360.[CrossRef]
    [Google Scholar]
  27. O'Neill, E. & Kolch, W. ( 2004; ). Conferring specificity on the ubiquitous Raf/MEK signalling pathway. Br J Cancer 90, 283–288.[CrossRef]
    [Google Scholar]
  28. Radkov, S. A., Kellam, P. & Boshoff, C. ( 2000; ). The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma–E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6, 1121–1127.[CrossRef]
    [Google Scholar]
  29. Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes, D. & Ganem, D. ( 1996; ). Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2, 342–346.[CrossRef]
    [Google Scholar]
  30. Satoh, T., Hoshikawa, Y., Satoh, Y., Kurata, T. & Sairenji, T. ( 1999; ). The interaction of mitogen-activated protein kinases to Epstein-Barr virus activation in Akata cells. Virus Genes 18, 57–64.[CrossRef]
    [Google Scholar]
  31. Vieira, J., O'Hearn, P., Kimball, L., Chandran, B. & Corey, L. ( 2001; ). Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J Virol 75, 1378–1386.[CrossRef]
    [Google Scholar]
  32. Yang, X., Chen, Y. & Gabuzda, D. ( 1999; ). ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-κB. J Biol Chem 274, 27981–27988.[CrossRef]
    [Google Scholar]
  33. Yang, T.-Y., Chen, S.-C., Leach, M. W. & 8 other authors ( 2000; ). Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191, 445–454.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81628-0
Loading
/content/journal/jgv/10.1099/vir.0.81628-0
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error